FMG Leading — a strategic advisory firm that partners with healthcare investors and executives to drive performance across the growth lifecycle — has acquired market intelligence and strategic advisory firm BroadBranch Advisors, as of July 31, 2026. Terms of the deal were not disclosed.
Responding to rising demand for sharper market intelligence across its client base, the acquisition gives executives and investors access to rigorous competitive and customer data, enhancing their ability to make confident strategic decisions and rapidly turn insights into action. By bringing together market insights, organizational health data, and outside-in context — supported by FMG Leading’s expert advisory team — the firm offers clients a uniquely integrated platform designed to strengthen competitive advantage in a challenging environment.
“In today’s high-pressure landscape, translating forward-looking intelligence into action faster and more effectively is critical for our clients, especially in the investor-backed healthcare space,” said Matt Brubaker, CEO and Chairman of FMG Leading. “By adding the market intelligence capabilities of BroadBranch Advisors, we’re further aligning our offerings to address this need, helping clients deliver on their performance, growth, and missional goals.”
“By capturing, synthesizing, and pressure testing information using an outside-in approach, we deliver the greatest possible assurance that clients have the data and insights they need to make the right decisions at the right time,” said Courtney Matson, Managing Partner at BroadBranch Advisors. “This effort magnifies FMG Leading’s now-integrated advisory and intelligence capabilities, allowing clients to ‘see around corners’ with a data-driven view that creates more value, lowers risk, and builds conviction.”
Read Also: Lunai Bioworks Names 10 Defendants in Naked Short Selling Fraud Suit
